Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 01, 2025

Get In Touch

Pulse Pharma Gets CDSCO Panel Nod to Manufacture, Market Aripiprazole Oral Solution Pharma News

Pulse Pharma Gets CDSCO Panel Nod to Manufacture, Market Aripiprazole Oral Solution

  • 29 October 2025
  • 2 days ago

Thermo Fisher Scientific inaugurates expanded RnD Centre of Excellence in Bengaluru Pharma News

Thermo Fisher Scientific inaugurates expanded RnD Centre of Excellence in Bengaluru

  • 29 October 2025
  • 2 days ago

Indian pharma, healthcare sector record 72 deals worth USD 3.5 billion in Q3 2025: Grant Thornton Bharat Pharma News

Indian pharma, healthcare sector record 72 deals worth USD 3.5 billion in Q3 2025: Grant Thornton Bharat

  • 29 October 2025
  • 2 days ago

India deepens anti dumping probe into imports of anti TB drug ingredient from China, Thailand Pharma News

India deepens anti dumping probe into imports of anti TB drug ingredient from China, Thailand

  • 29 October 2025
  • 2 days ago

Doctors Slam FSSAI Inaction After Delhi HC Allows ORSL Sales, Warn of Child Health Risks Pharma News

Doctors Slam FSSAI Inaction After Delhi HC Allows ORSL Sales, Warn of Child Health Risks

  • 29 October 2025
  • 2 days ago

FSSAI Bar on Dr Reddy's Nutraceutical Put on Hold: Delhi HC Awaits Regulatory Hearing Outcome Pharma News

FSSAI Bar on Dr Reddy's Nutraceutical Put on Hold: Delhi HC Awaits Regulatory Hearing Outcome

  • 29 October 2025
  • 2 days ago

Koselugo approved in EU for plexiform neurofibromas in adults with neurofibromatosis type 1: AstraZeneca Pharma News

Koselugo approved in EU for plexiform neurofibromas in adults with neurofibromatosis type 1: AstraZeneca

  • 29 October 2025
  • 2 days ago

Lupin inaugrates new corporate offices in New Jersey Pharma News

Lupin inaugrates new corporate offices in New Jersey

  • 29 October 2025
  • 2 days ago

Alembic Pharma wins USFDA nod for heart disease drug Pharma News

Alembic Pharma wins USFDA nod for heart disease drug

  • 29 October 2025
  • 2 days ago

Granules India gets USFDA EIR for Bonthapally facility Pharma News

Granules India gets USFDA EIR for Bonthapally facility

  • 29 October 2025
  • 2 days ago

Recent News

Global review links common viral infections to hig...

  • 01 November, 2025

Lower ketone levels and improved exercise capacity...

  • 01 November, 2025

Citrus Flavonoids effective nutritional adjunct to...

  • 01 November, 2025

Daily kimchi intake linked to reduced BMI and bell...

  • 01 November, 2025

Aggressive Risk Factor Management Reduces AF Recur...

  • 01 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.